Alpha-blockers impact stent-related symptoms: A randomized, double-blind, placebo-controlled trial

Journal of Endourology

Volumn 26, Issue 9, 2012, Pages 1237-1241

  Nazim, Syed M ^a   Ather, M Hammad ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ANTIBIOTIC AGENT; DICLOFENAC; PARACETAMOL; PLACEBO;

ADULT; ANALGESIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DYSURIA; FEMALE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; NOSE CONGESTION; ORTHOSTATIC DIZZINESS; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STRESS INCONTINENCE; URETER STENT; URETER STONE; URETEROSCOPY; URGE INCONTINENCE; URINARY FREQUENCY; URINARY TRACT DISEASE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLACEBOS; QUESTIONNAIRES; QUINAZOLINES; STENTS; URETER;

EID: 84865740508     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2012.0036     Document Type: Article

References (19)

1. Chew BH, Knudsen BE, Denstedt JD. The use of stents in contemporary urology. Curr Opin Urol 2004;14:111-115.
2. Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of longterm indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 1967;97:840-844.
3. Irani J, Siquier J, Pirès C, et al. Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int 1999;84:276-279.
4. Joshi HB, Stainthorpe A, MacDonagh RP, et al. Indwelling ureteral stents: Evaluation of symptoms, quality of life and utility. J Urol 2003;169:1065-1069.
5. Wang CJ, Huang SW, Chang CH. Effects of specific alpha- 1A/1D blocker on lower urinary tract symptoms due to double-J stent: A prospectively randomized study. Urol Res 2009;37:147-152.
6. Rane A, Saleemi A, Cahill D, et al. Have stent-related symptoms anything to do with placement technique? J Endourol 2001;15:741-745.
7. Ather MH, Talati J, Biyabani R. Physician responsibility for removal of implants: The case for a computerized program for tracking overdue double-J stents. Tech Urol 2000;6: 189-192.
8. Deliveliotis C, Chrisofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006;67:35-9.
9. Hofner K, Jonas U. Alfuzosin: A clinically uroselective alpha1- blocker. World J UroA 2002;19:405-12.
10. Hampel C, Gillitzer R, Pahernik S, et al. [Drug therapy of female urinary incontinence.] (Ger) Urologe A 2005;44:244- 255.
11. Serels S, Stein M. Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women. Neurourol Urodyn 1998;17:31-36.
12. Keeley FX Jr, Timoney AG. Routine stenting after ureteroscopy: Think again. Eur Urol 2007;52:642-644.
13. Candela JV, Bellman GC. Ureteral stents: Impact of diameter and composition on patient symptoms. J Endourol 1997;11:45-47.
14. Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J Endourol 1993;7:137-140.
15. Beddingfield R, Pedro RN, Hinck B, et al. Alfuzosin to relieve ureteral stent discomfort: A prospective, randomized, placebo controlled study. J Urol 2009;181:170-176.
16. Lee SJ, Yoo C, Oh CY, et al. Stent position is more important than a-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: A prospective randomized study. Korean J Urol 2010;51:636-641.
17. Giannarini G, Keeley FX Jr, Valent F, et al. Predictors of morbidity in patients with indwelling ureteric stents: Results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int 2011;107:648-654.
18. Navanimitkul N, Lojanapiwat B. Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: A randomized controlled study. J Int Med Res 2010;38:1436- 1441.
19. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: Development and validation of a multidimensional quality of life measure. J Urol 2003;169: 1060-1064.